| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biological and Medical Research Division, Argonne National Laboratory, Argonne, Illinois 60439 [F. R. C., C. B. C., E. H.], and Northwestern University Medical School, The Children's Memorial Institute for Education and Research, Chicago, Illinois 60614 [B. L. M.]
Inosine-5'-phosphate (IMP) dehydrogenase, a regulatory enzyme of guanine nucleotide biosynthesis, may play a role in cell proliferation and malignancy. To assess this role we examined IMP dehydrogenase expression in a series of human solid tumor tissues and tumor cell lines in comparison with their normal counterparts. Increased IMP dehydrogenase gene expression was observed in brain tumors relative to normal brain tissue and in sarcoma cells relative to normal fibroblasts. Similarly, in several B- and T-lymphoid leukemia cell lines, elevated levels of IMP dehydrogenase mRNA and cellular enzyme were observed in comparison with the levels in peripheral blood lymphocytes. These results are consistent with an association between increased IMP dehydrogenase expression and either enhanced cell proliferation or malignant transformation.
1 This work was supported by the United States Department of Energy, Office of Health and Environmental Research under Contract W-31-109-ENG-38.
Received 7/20/92. Accepted 9/ 1/92.
This article has been cited by other articles:
![]() |
L. C.S. Tam, A.-S. Kiang, A. Kennan, P. F. Kenna, N. Chadderton, M. Ader, A. Palfi, A. Aherne, C. Ayuso, M. Campbell, et al. Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10) Hum. Mol. Genet., July 15, 2008; 17(14): 2084 - 2100. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Ku, M. McCartan, and D. Collier Clinical Pharmacokinetic and Pharmacodynamic Monitoring for Mycophenolate Mofetil Journal of Pharmacy Practice, December 1, 2005; 18(6): 422 - 431. [Abstract] [PDF] |
||||
![]() |
L. Rambhatla, S. Ram-Mohan, J. J. Cheng, and J. L. Sherley Immortal DNA Strand Cosegregation Requires p53/IMPDH-Dependent Asymmetric Self-renewal Associated with Adult Stem Cells Cancer Res., April 15, 2005; 65(8): 3155 - 3161. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Gu, A. K. Tolin, J. Jain, H. Huang, L. Santiago, and B. S. Mitchell Targeted Disruption of the Inosine 5'-Monophosphate Dehydrogenase Type I Gene in Mice Mol. Cell. Biol., September 15, 2003; 23(18): 6702 - 6712. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Escobar-Henriques, M. A. Collart, and B. Daignan-Fornier Transcription Initiation of the Yeast IMD2 Gene Is Abolished in Response to Nutrient Limitation through a Sequence in Its Coding Region Mol. Cell. Biol., September 1, 2003; 23(17): 6279 - 6290. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, S. A. Bohn, and J. L. Sherley Inosine-5'-Monophosphate Dehydrogenase Is a Rate-determining Factor for p53-dependent Growth Regulation Mol. Biol. Cell, January 1, 1998; 9(1): 15 - 28. [Abstract] [Full Text] |
||||
![]() |
A. Griesmacher, G. Weigel, G. Seebacher, and M. M. Muller IMP-dehydrogenase inhibition in human lymphocytes and lymphoblasts by mycophenolic acid and mycophenolic acid glucuronide Clin. Chem., December 1, 1997; 43(12): 2312 - 2317. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Zimmermann, K. L. Wright, J. P.-Y. Ting, and B. S. Mitchell Regulation of Inosine-5'-monophosphate Dehydrogenase Type II Gene Expression in Human T Cells. ROLE FOR A NOVEL 5' PALINDROMIC OCTAMER SEQUENCE J. Biol. Chem., September 5, 1997; 272(36): 22913 - 22923. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Gu, J. Spychala, and B. S. Mitchell Regulation of the Human Inosine Monophosphate Dehydrogenase Type I Gene. UTILIZATION OF ALTERNATIVE PROMOTERS J. Biol. Chem., February 14, 1997; 272(7): 4458 - 4466. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Farazi, J. Leichman, T. Harris, M. Cahoon, and L. Hedstrom Isolation and Characterization of Mycophenolic Acid-resistant Mutants of Inosine-5'-monophosphate Dehydrogenase J. Biol. Chem., January 10, 1997; 272(2): 961 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nimmesgern, T. Fox, M. A. Fleming, and J. A. Thomson Conformational Changes and Stabilization of Inosine 5'-Monophosphate Dehydrogenase Associated with Ligand Binding and Inhibition by Mycophenolic Acid J. Biol. Chem., August 9, 1996; 271(32): 19421 - 19427. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Xiang, J. C. Taylor, and G. D. Markham Monovalent Cation Activation and Kinetic Mechanism of Inosine 5`-Monophosphate Dehydrogenase J. Biol. Chem., January 19, 1996; 271(3): 1435 - 1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Zimmermann, J. Spychala, and B. S. Mitchell Characterization of the Human Inosine-5`-monophosphate Dehydrogenase Type II Gene J. Biol. Chem., March 24, 1995; 270(12): 6808 - 6814. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Escobar-Henriques and B. Daignan-Fornier Transcriptional Regulation of the Yeast GMP Synthesis Pathway by Its End Products J. Biol. Chem., January 5, 2001; 276(2): 1523 - 1530. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |